COPD Foundation congratulates Califf on confirmation as new FDA commissioner
February 25, 2016 |
WASHINGTON, D.C. - February 25, 2016 - The COPD Foundation congratulates Robert Califf, MD, on his confirmation as the new commissioner of the U.S. Food and Drug Administration (FDA).
The U.S. Senate confirmed Califf on February 24 by an overwhelming vote of 89-4. Califf, 63, joined the FDA as deputy commissioner in March 2015 after more than 30 years as a prominent cardiologist and medical researcher at Duke University. He is among the most cited medical authors in academia, with more than 1,200 journal articles.
“On behalf of the COPD Foundation, I am pleased that Commissioner Califf has been appointed to this new role. We look forward to working with him on many initiatives,” said Craig Kephart, Executive Director of the COPD Foundation. He continued, “I know our founder John W. Walsh thinks incredibly highly of him and considers the Commissioner to be a leader in the healthcare field dedicated to advancing medicine.”